
Please try another search
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Name | Age | Since | Title |
---|---|---|---|
Braeden William Lichti | - | 2024 | Non-Executive Chairman |
Eduardo Grunvald | - | 2024 | Member of Scientific Advisory Board |
Graydon Bensler | 33 | 2020 | CEO, CFO, Secretary & Director |
George Kovalyov | 40 | 2024 | Independent Director |
Juliana L. Daley | 37 | 2023 | Independent Director |
Jeffrey Owen Parry | 65 | 2023 | Independent Director |
Roger A. Fielding | - | 2024 | Member of Scientific Advisory Board |
Orian Shirihai | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review